companydata.dkcompanydata.dk

Novo Nordisk Pharmatech A/S: Financial statements 2014

CVR: 13246149

Source: annual report 2014, Danish Business Authority

01/01/2014 – 31/12/2014

Novo Nordisk Pharmatech A/S (CVR 13246149) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 495,202,000 and a net result of DKK 55,343,000 compared with DKK 46,703,000 the year before. That is a decrease of 0.6% compared with the year before. The profit margin was 11.2%. Equity in the 2014 report amounted to DKK 336,817,000. The solvency ratio was 74.5%. The company had 150 employees in the financial year.

Revenue
DKK 495,202,000
Gross Profit
DKK 176,596,000
Profit/Loss
DKK 55,343,000
Equity
DKK 336,817,000
Total Assets
DKK 452,142,000
Employees
150

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014495.2M176.6M55.3M336.8M150
2013498M170.7M46.7M304.5M141

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

Novo Nordisk Pharmatech A/S: The 2013 annual report is outMar 30, 2014

Novo Nordisk Pharmatech A/S has published its annual report for 2013. Revenue came to DKK 497,979,000, and the net result was DKK 46,703,000.

About Novo Nordisk Pharmatech A/S

Novo Nordisk Pharmatech A/S is a Danish company of the type Aktieselskab based in Køge, founded in 1989. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named FEF CHEMICALS A/S and FERROSAN FINE CHEMICALS A/S. The management consists of Ulla Grove Krogsgaard Thomsen. The board consists of Mette Sofie Mørck Jarl (chair), Christian Brøgger Stolberg, Jacob Sten Petersen and Joachim Juel Hagemeister. The company is owned by NOVO NORDISK A/S. The company has 489 employees (2026). In 2025, the company reported revenue of DKK 1,041,584,000 and a net result of DKK 113,891,000 compared with DKK 60,619,000 the year before. Equity in the 2025 report amounted to DKK 2,441,318,000.

Source: annual report 2025, Danish Business Authority